US NIH National Institute on Aging (NIA): Integrative Omics to Enhance Therapeutics Development for Healthy Aging (UH2/UH3 Clinical Trial Not Allowed)

This opportunity uses the UH2/UH3 Phase Innovation Awards Cooperative Agreement funding mechanism.

Funding Opportunity Announcement (FOA) Number: RFA-AG-19-011

This announcement invites the submission of a single cooperative agreement and phased innovation UH2/UH3 to identify omics profiles associated with protection against multiple aging conditions and with exceptional health span and refine strategies for utilising these profiles in therapeutics development.

Funding & Duration

Application budgets should not exceed USD $3.3M (approx. AUD $4.5M) in direct costs.


Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Submission Requirements & Due Dates

Further Information

Need Help?

This entry was posted in Engineering, Computer & Mathematical Sciences, Funding by Award Type, Grants (Project Funds), International Funding, Sciences. Bookmark the permalink.

Comments are closed.